Arun Kashyap

Arun Kashyap

Company: Arch Oncology

Job title: Vice President


AO-176, A Highly differentiated Clinical Stage Anti-CD47 Antibody, Demonstrates In vitro Phagocytosis and In vivo Efficacy in Multiple Lymphoma Models 9:30 am

AO-176 treatment induces phagocytosis of multiple lymphoma cell lines in vitro AO-176-treatment of mice with established lymphoma xenograft tumors caused tumor shrinkage in multiple models and was well toleratedRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.